Scinovex
articleTop 1% cited

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease

Archives of Neurology · 2006 · Vol. 63(11) · pp. 1545–1545
Ernst J. SchaeferVanina BongardAlexa BeiserStefania Lamon‐FavaSander J. RobinsRhoda AuKatherine L. TuckerDavid J. KylePeter W.F. WilsonPhilip A. Wolf

Abstract

The top quartile of plasma PC DHA level was associated with a significant 47% reduction in the risk of developing all-cause dementia in the Framingham Heart Study.

Fatty Acid Research and HealthFolate and B Vitamins ResearchBirth, Development, and HealthDementiaDocosahexaenoic acidInternal medicineQuartileConfidence intervalAlzheimer's diseaseMedicineRelative riskEndocrinologyGastroenterology

MeSH terms

AgedAged, 80 and overAlzheimer DiseaseDementiaDocosahexaenoic AcidsFemaleFollow-Up StudiesHumansMaleMental Status SchedulePhosphatidylcholinesProspective StudiesRiskIncidenceProportional Hazards Models

Funding

  • U.S. Department of Agriculture
  • Pfizer
  • University of Connecticut
  • National Institutes of Health
  • National Institute on Aging
  • National Heart, Lung, and Blood Institute
Citations
681
FWCI
27.88
field-weighted impact
References
28
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease · Scinovex